| Metric | Q1 2025 | Q4 2024 | Q1 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $210M | — | — | — | — |
| Op. Income | $13M | — | — | — | — |
| Gross Margin | 14.0% | — | — | — | — |
| Net Margin | 3.7% | — | — | — | — |
| EPS (Diluted) | $0.22 | — | — | — | — |
| Free Cash Flow | -$23M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $210M |
| Cost of Revenue | $180M |
| GROSS PROFIT | $29M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $15M |
| SG&A Expenses | $15M |
| Other Expenses | $2M |
| Operating Expenses | $17M |
| Cost & Expenses | $197M |
| OPERATING INCOME | $13M |
| Interest Income | $0 |
| Interest Expense | $1M |
| Other Income/Expenses | -$1M |
| INCOME BEFORE TAX | $11M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $9M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $8M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $8M |
| D&A | $2M |
| EBIT | $13M |
| EBITDA | $14M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $210M |
| Cost of Revenue | $180M |
| GROSS PROFIT | $29M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $15M |
| SG&A Expenses | $15M |
| Other Expenses | $2M |
| Operating Expenses | $17M |
| Cost & Expenses | $197M |
| OPERATING INCOME | $13M |
| Interest Income | $0 |
| Interest Expense | $1M |
| Other Income/Expenses | -$1M |
| INCOME BEFORE TAX | $11M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $9M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $8M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $8M |
| D&A | $2M |
| EBIT | $13M |
| EBITDA | $14M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $8M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $915.0K |
| Other Non-Cash Items | $3M |
| Change in Working Capital | -$35M |
| OPERATING CASH FLOW | -$21M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | -$48M |
| Purchases of Investments | -$1M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $645.0K |
| NET CASH FROM INVESTING | -$50M |
| Net Debt Issuance | $53M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$387.0K |
| NET CASH FROM FINANCING | $53M |
| FREE CASH FLOW | -$23M |
| Net Change in Cash | -$19M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $5M |
| Short-Term Investments | $0 |
| Net Receivables | $95M |
| Inventory | $0 |
| Other Current Assets | $24M |
| TOTAL CURRENT ASSETS | $124M |
| PP&E (Net) | $322M |
| Goodwill | $155M |
| Intangible Assets | $119M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $24M |
| TOTAL NON-CURRENT ASSETS | $620M |
| TOTAL ASSETS | $744M |
| Account Payables | $19M |
| Short-Term Debt | $0 |
| Deferred Revenue | $2M |
| Other Current Liabilities | $238.0K |
| TOTAL CURRENT LIABILITIES | $88M |
| Long-Term Debt | $53M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $3M |
| Other Non-Current Liabilities | $17M |
| TOTAL NON-CURRENT LIABILITIES | $333M |
| TOTAL LIABILITIES | $421M |
| Common Stock | $35.0K |
| Additional Paid-In Capital | $239M |
| Retained Earnings | $65M |
| Treasury Stock | -$65.0K |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $304M |
| Minority Interest | $19M |
| TOTAL EQUITY | $323M |
| TOTAL LIABILITIES & EQUITY | $744M |
| Total Debt | $333M |
| Net Debt | $328M |
